Human EGFR/ALK Gene Mutation Combined Detection Reagent Kit

Molecular assay kit detecting EGFR gene mutations including EGFR-19del variant in tissue DNA and plasma cell-free DNA. Supports non-small cell lung cancer patient stratification and treatment selection.

Molecular assay for detecting EGFR gene mutations including 19-deletion variant in tissue and plasma circulating free DNA. Supports treatment selection and monitoring in non-small cell lung cancer patients.

FISH-based kit for detecting ALK gene translocations in lung and other malignancies. The test enables identification of ALK-positive tumors for appropriate therapeutic targeting.

This kit is used to in vitro qualitatively detect common mutations in exons 18-21 of the EGFR gene in samples from human non-small cell lung cancer patients.

A diagnostic kit for detecting ALK gene fusions. Applied in solid tumour oncology for identifying anaplastic lymphoma kinase rearrangements in cancer samples.

A real-time PCR diagnostic kit for EGFR mutation detection. Used in solid tumour oncology for identifying epidermal growth factor receptor mutations in patient samples.

PCR-based molecular diagnostic kit for detection of epidermal growth factor receptor mutations in solid tumors. Supports personalized cancer treatment planning and targeted therapy selection.

A diagnostic kit based on GENETRON's proprietary 'one-step method' technology enabling completion of library construction in 1.5 to 3 hours (China patent ZL 201710218529.4). It detects EGFR, KRAS, BRAF, HER2, and PIK3CA gene mutations in DNA and ALK and ROS1 gene fusions in RNA from FFPE tissue samples of non-small cell lung cancer patients, as well as MET gene 14 exon skipping mutations.

In vitro diagnostic kit for detecting EGFR gene mutations in patient samples. Enables molecular profiling of epidermal growth factor receptor status to guide targeted cancer therapy selection and treatment planning in oncology.

Comprehensive genetic screening kit for lung cancer biomarkers and mutations. Enables early detection and treatment planning for pulmonary malignancies.

A diagnostic test kit for detecting mutations associated with lung cancer. This panel identifies genetic alterations relevant to lung cancer diagnosis and treatment planning.

QLoci™ Prima ADK is an application development kit for liquid biopsy-based genetic testing, enabling detection of mutations such as EGFR T790M in lung cancer patients. This platform facilitates non-invasive blood-based testing as an alternative to tissue biopsy, supporting clinical decision-making for targeted therapy selection in advanced-stage disease.